“…Pancreatic CSCs contribute to tumor cell self‐renewal, differentiation, cancer recurrence, metastasis, and therapy resistance 4,5 . Markers that used to identify pancreatic CSCs include SOX2, OCT4, NANOG, ALDH1, CD24, CD44, and ESA 6,7 . Pancreatic CSCs are regulated by aberrant activation of signal pathways like NOTCH, WNT, and β‐catenin 8,9 .…”